Literature DB >> 19687323

Trastuzumab beyond disease progression: case closed?

Giorgio Valabrega, Massimo Aglietta, Filippo Montemurro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19687323     DOI： 10.1200/JCO.2009.23.8873

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies.

Authors:  Michael Luis; Ana Tavares; Liliana S Carvalho; Lúcio Lara-Santos; António Araújo; Ramon Andrade de Mello
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

2.  Lapatinib - Member of a New Generation of ErbB-Targeting Drugs.

Authors:  Michael Untch; Hans-Joachim Lück
Journal:  Breast Care (Basel)       Date:  2010-04-26       Impact factor: 2.860
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.